"Nitric Oxide Donors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81)
| Descriptor ID |
D020030
|
| MeSH Number(s) |
D27.505.519.656 D27.505.954.411.590
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nitric Oxide Donors".
Below are MeSH descriptors whose meaning is more specific than "Nitric Oxide Donors".
This graph shows the total number of publications written about "Nitric Oxide Donors" by people in this website by year, and whether "Nitric Oxide Donors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 1 | 2 |
| 2007 | 1 | 1 | 2 |
| 2010 | 0 | 1 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 4 | 3 | 7 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Nitric Oxide Donors" by people in Profiles.
-
Effects of nitrite and far-red light on coagulation. Nitric Oxide. 2021 02 01; 107:11-18.
-
Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro. Redox Biol. 2020 10; 37:101734.
-
Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19. Nitric Oxide. 2020 10 01; 103:4-8.
-
Potential of NO donor furoxan as SARS-CoV-2 main protease (Mpro) inhibitors: in silico analysis. J Biomol Struct Dyn. 2021 Sep; 39(15):5804-5818.
-
Desperate Times, Desperate Measures: The Case for RRx-001 in the Treatment of COVID-19. Semin Oncol. 2020 10; 47(5):305-308.
-
Is it Possible to Significantly Modify Blood Pressure with a Combined Nutraceutical on Top of a Healthy Diet? The Results of a Pilot Clinical Trial. High Blood Press Cardiovasc Prev. 2018 Dec; 25(4):401-405.
-
Alterations of tumor microenvironment by nitric oxide impedes castration-resistant prostate cancer growth. Proc Natl Acad Sci U S A. 2018 10 30; 115(44):11298-11303.
-
New Nitric Oxide Donor NCX 1443: Therapeutic Effects on Pulmonary Hypertension in the SAD Mouse Model of Sickle Cell Disease. J Cardiovasc Pharmacol. 2018 05; 71(5):283-292.
-
Sildenafil normalizes MALAT1 level in diabetic cardiomyopathy. Endocrine. 2018 10; 62(1):259-262.
-
Effect of a nitric oxide donor on maternal hemodynamics in fetal growth restriction. Ultrasound Obstet Gynecol. 2018 Apr; 51(4):514-518.